BRIEF published on 04/02/2024 at 15:05, 1 year 10 months ago Edesa Biotech participera aux prochaines conférences d'investisseurs Immunothérapie Essais Cliniques Produits Biopharmaceutiques Edesa Biotechnologie Conférences Investisseurs
PRESS RELEASE published on 04/02/2024 at 15:00, 1 year 10 months ago Edesa Biotech to Participate in Upcoming Investor Conferences Edesa Biotech, Inc. announces participation in upcoming investor conferences in Toronto, London, and New York to present innovative treatments for immuno-inflammatory diseases Clinical-stage Biopharmaceutical Company Immuno-inflammatory Diseases Investor Conferences Edesa Biotech Inc. Therapeutics
BRIEF published on 03/21/2024 at 21:35, 1 year 10 months ago Edesa Biotech participera à la conférence HC Wainwright sur les maladies auto-immunes et inflammatoires Maladies Inflammatoires Edesa Biotechnologie Conférence Auto-immune Discussion Au Coin Du Feu Produits Biopharmaceutiques Au Stade Clinique
BRIEF published on 03/21/2024 at 21:35, 1 year 10 months ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Fireside Chat Edesa Biotech Inflammatory Diseases Autoimmune Conference Clinical-Stage Biopharmaceutical
PRESS RELEASE published on 03/21/2024 at 21:30, 1 year 10 months ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Edesa Biotech to participate in H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference. Fireside Chat with CEO Par Nijhawan, MD and analyst scheduled for March 28, 2024 Fireside Chat Edesa Biotech H.C. Wainwright Autoimmune & Inflammatory Disease Par Nijhawan
BRIEF published on 03/07/2024 at 14:50, 1 year 11 months ago Edesa Biotech to Showcase at Barclays Global Healthcare Conference Clinical Trials Edesa Biotech Immunotherapy Barclays Healthcare Conference ARDS
BRIEF published on 03/07/2024 at 14:50, 1 year 11 months ago Edesa Biotech sera présent à la conférence Barclays Global Healthcare Immunothérapie Essais Cliniques Edesa Biotechnologie Conférence Barclays Sur La Santé SDRA
PRESS RELEASE published on 03/07/2024 at 14:45, 1 year 11 months ago Edesa Biotech to Participate in Barclays Global Healthcare Conference Edesa Biotech, Inc. (NASDAQ:EDSA) to participate in Barclays 26th Annual Global Healthcare Conference in Miami. Company focuses on developing host-directed therapeutics for immuno-inflammatory diseases Biopharmaceutical Company Edesa Biotech NASDAQ:EDSA Barclays 26th Annual Global Healthcare Conference Immune-related Diseases
BRIEF published on 03/04/2024 at 22:35, 1 year 11 months ago Edesa Biotech participera aux prochaines réunions de dermatologie Biopharmaceutique Essais Cliniques Edesa Biotechnologie Dermatologie Maladies Immuno-inflammatoires
BRIEF published on 03/04/2024 at 22:35, 1 year 11 months ago Edesa Biotech to Participate in Upcoming Dermatology Meetings Immuno-inflammatory Diseases Clinical Trials Biopharmaceutical Edesa Biotech Dermatology
Published on 02/08/2026 at 21:00, 1 hour 30 minutes ago Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 1 day 21 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 23 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 2 days ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 7 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/07/2026 at 21:00, 1 day 1 hour ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 5 hours ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 6 hours ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 2 days 3 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days 4 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 2 days 4 hours ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 2 days 4 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 6 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 2 days 6 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 14 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
